Ducol Organics & Colours H1 FY27 Revenue Rises 74%
Key highlights
- Ducol Organics & Colours reported H1 FY27 consolidated revenue of ₹112.26 crore, up 74% year on year.
- Bitumag and XChem contributed combined H1 FY27 revenue of ₹64.46 crore.
- Consolidated EBITDA was ₹12.79 crore at an 11.39% margin, while PAT was ₹6.47 crore.
- Management has targeted ₹400 crore to ₹500 crore of consolidated revenue within three years.
powered by IRIS

Ducol Organics & Colours Ltd reported consolidated H1 FY27 revenue of ₹112.26 crore, up 74% year on year, with acquired businesses Bitumag and XChem contributing a combined ₹64.46 crore. The performance places acquisition-led diversification at the centre of the company’s plan to reach ₹400 crore to ₹500 crore of revenue within three years.
Know Ducol Organics & Colours inside out
Results, valuation, peers and who's buying, in one view.
How did Ducol Organics & Colours perform in H1 FY27?
Ducol Organics & Colours reported consolidated revenue from operations of ₹112.26 crore for the first half of FY27, compared with ₹64.52 crore in the comparable previous-year period. Consolidated EBITDA stood at ₹12.79 crore, translating into an EBITDA margin of 11.39%. Profit after tax was ₹6.47 crore.
The company held its maiden earnings call on November 16, 2026, following its H1 FY27 results. Management presented the period as one in which the business mix expanded beyond its standalone pigment-dispersion operations through Bitumag and XChem. The reported 74% revenue growth was therefore substantially supported by the acquired entities rather than only by the pre-existing standalone business.
Standalone revenue was ₹48.71 crore in H1 FY27, while standalone EBITDA was ₹6.70 crore and standalone PAT was ₹2.15 crore. These figures separate the contribution of the original business from the consolidated performance that includes the acquired operations.
What drove Ducol Organics & Colours' revenue growth?
Ducol Organics & Colours' revenue increase was driven principally by Bitumag and XChem, which generated ₹32.62 crore and ₹31.84 crore, respectively, during H1 FY27. Together, the two businesses accounted for ₹64.46 crore of consolidated revenue, exceeding half of the reported total.
The two acquired units also generated combined EBITDA of ₹6.09 crore. Bitumag contributed ₹3 crore of EBITDA, while XChem contributed ₹3.09 crore. This indicates that the acquisitions were material to both revenue and operating-profit generation during the half year.
Management linked the diversification strategy to opportunities in specialty chemicals, infrastructure-linked demand and cross-selling. However, the earnings-call material did not provide quantified demand forecasts, order-book figures or a detailed revenue bridge for the proposed three-year growth plan. Investors therefore have reported targets and H1 contributions, but not a disclosed annual progression toward those targets.
XChem's utilisation was reported at about 30% to 35%. This leaves scope for higher use of existing capacity, although the company did not provide a timetable or quantified revenue benefit associated with any improvement in utilisation.
Got a follow-up? Ask IRIS
What are Ducol Organics & Colours' stated growth and margin targets?
Ducol Organics & Colours has stated an objective of scaling consolidated revenue to ₹400 crore to ₹500 crore over the next three years. Management referred to 25% to 30% annual growth in the acquired businesses and indicated that greater capacity utilisation would be part of the expansion plan.
The company also targets a consolidated EBITDA margin of 12% to 15%, compared with the H1 FY27 consolidated margin of 11.39%. The acquired units were described as operating at approximately 9% to 10% EBITDA margins, below the stated consolidated margin objective. The difference makes integration, utilisation and operating improvement relevant factors in assessing progress toward the target range.
Management indicated that maintenance capital expenditure may be limited to ₹5 crore to ₹7 crore while using existing capacity more intensively. This is a stated capital-allocation approach, not a commitment to a specific expansion outcome. No detailed capital-expenditure schedule or annual financing plan was disclosed in the supplied call summary.
Exports currently account for about 10% of sales, according to the earnings-call material. The company aims to raise that share to about 25%. It also identified Bangladesh as an addressable market estimated at roughly one-fourth the size of India, providing context for its export ambition.
What should investors assess after the H1 FY27 earnings call?
Investors should assess the relative roles of acquired-business growth, standalone operations and margin improvement in Ducol Organics & Colours' future results. H1 FY27 showed that Bitumag and XChem were central to the reported increase in consolidated revenue, so subsequent disclosures on their sales, profitability and capacity utilisation will be important for comparing the revenue target with actual execution.
The margin profile is another relevant measure. Consolidated EBITDA margin was 11.39%, while management's longer-term aim is 12% to 15% and the acquired units were reported at approximately 9% to 10%. The figures establish a measurable gap between the H1 outcome and the stated target, without establishing when the company expects to close it.
Finance cost was reported at ₹1.79 crore. The company also disclosed that the share-purchase agreement for 100% of XChem Polymers India was signed on March 26, 2026, for aggregate consideration of approximately ₹75 crore. These facts provide context for the increased consolidated scale and for the financial items investors may track in later results.
For customers and industry participants, the company's focus on existing capacity and export expansion indicates an effort to broaden the operational base of its chemical businesses. The supplied material does not disclose changes in customer pricing, employment, production volumes or market share, so conclusions on those areas cannot be drawn from the H1 call alone.
Conclusion
Ducol Organics & Colours delivered H1 FY27 consolidated revenue growth of 74% to ₹112.26 crore, with Bitumag and XChem contributing ₹64.46 crore. EBITDA of ₹12.79 crore and PAT of ₹6.47 crore show the financial scale of the combined business, while the reported figures also make clear that acquisitions were the principal contributor to the period's growth.
The next results will show whether the company can increase XChem utilisation, lift acquired-unit margins from approximately 9% to 10%, and progress toward its ₹400 crore to ₹500 crore revenue objective. Investors will also watch for disclosures on export growth toward the stated 25% sales share and maintenance capex of ₹5 crore to ₹7 crore.


